Address
7 Hogue St, Maryville, Newcastle NSW 2293, Australia
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM
Address
7 Hogue St, Maryville, Newcastle NSW 2293, Australia
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM

Where do i buy recreational marijuana Online Melbourne? Marijuana, also called cannabis, is one of the world’s most widely used psychoactive substances. As cannabis laws and attitudes have changed in many countries, researchers have devoted increasing attention to an important question: How does marijuana affect mental health?
The answer is more complicated than simply saying cannabis is either harmful or beneficial. Research has identified associations between cannabis use and several mental health conditions, including psychosis, schizophrenia, depression, anxiety, bipolar disorder, and suicidal behaviors. At the same time, scientists continue to investigate why these relationships occur and why effects can differ considerably from one person to another. Where do i buy recreational marijuana Online Melbourne?
The strongest evidence concerns the relationship between frequent cannabis use and psychosis. A 2026 review published in The Lancet Psychiatry concluded that there is credible evidence that daily cannabis use contributes to psychosis, while noting that relationships with depression, anxiety, bipolar disorder, and suicidal behavior remain less certain and can involve multiple factors.
This article examines what current research says about marijuana and mental health, including possible short-term effects, long-term risks, the role of THC potency and frequency of use, effects on young people, cannabis use disorder, and the limitations of existing research. Where do i buy recreational marijuana Online Melbourne?
Marijuana refers to cannabis products containing cannabinoids, chemical compounds that interact with the body’s endocannabinoid system. The two cannabinoids most frequently discussed in relation to mental health are tetrahydrocannabinol (THC) and cannabidiol (CBD).
THC is primarily responsible for the intoxicating effects associated with cannabis. It can alter perception, memory, mood, attention, and coordination. CBD does not produce the same intoxicating effect as THC, although products marketed as containing CBD can vary considerably in composition and quality.
Modern cannabis products can also contain substantially higher concentrations of THC than products traditionally studied in older research. This is important because the mental-health effects of cannabis can depend on the amount of THC consumed, how often it is used, the age at which use begins, and individual vulnerability.
The National Institute on Drug Abuse (NIDA) marijuana research information notes that frequent or heavy cannabis use has been associated with problems involving learning, memory, attention, processing speed, and other cognitive functions.
Research does not support one simple conclusion that applies equally to everyone who uses cannabis.
Some people report temporary feelings of relaxation or euphoria after using marijuana. Others experience anxiety, panic, paranoia, confusion, or unpleasant thoughts. Longer-term observational studies have identified associations between cannabis use and several psychiatric outcomes.
The evidence is particularly concerning when cannabis is:
Used daily or almost daily
Started during adolescence
High in THC
Used in large amounts
Used by someone with a personal or family history of psychosis
Used alongside other substances
Used by someone who already has a serious mental health disorder
The Centers for Disease Control and Prevention (CDC) cannabis and mental health information states that cannabis use has been associated with psychosis, schizophrenia, depression, social anxiety, and suicidal thoughts and behaviors, while also emphasizing that researchers do not fully understand all of these relationships.
Cannabis can produce noticeable psychological effects within a relatively short period after consumption.
Depending on the dose and individual, short-term effects may include:
Euphoria
Relaxation
Altered perception of time
Increased sensitivity to sights and sounds
Impaired short-term memory
Reduced attention
Confusion
Anxiety
Panic
Paranoia
Disorientation
For some people, particularly those who consume a large amount of THC, anxiety or paranoia can become intense.
Cannabis can also occasionally produce temporary psychotic symptoms, such as severe paranoia, hallucinations, or difficulty distinguishing unusual perceptions from reality. These symptoms may resolve as intoxication wears off, but experiencing cannabis-related psychotic symptoms is clinically important because cannabis use is also associated with an increased longer-term risk of psychotic disorders.
The World Health Organization’s cannabis information provides an updated overview of the health and social consequences of nonmedical cannabis use, including cannabis use disorder and mental-health-related concerns.
The relationship between cannabis and psychosis is one of the most extensively studied areas of cannabis mental-health research.
Psychosis describes a state in which a person can lose contact with reality. Symptoms can include hallucinations, delusions, severe paranoia, and disorganized thinking.
The evidence indicates that cannabis use is associated with a greater risk of psychosis, particularly among frequent users. Where do i buy recreational marijuana Online Melbourne?
The National Academies of Sciences, Engineering, and Medicine found substantial evidence of a statistical association between cannabis use and development of schizophrenia or other psychotic disorders, with the highest risk observed among the most frequent users.
More recent research has strengthened this concern. The 2026 Lancet Psychiatry review concluded that the evidence supports daily cannabis use as a contributory cause of psychosis.
However, this does not mean every person who uses marijuana will develop psychosis. Most cannabis users do not develop schizophrenia.
Risk appears to vary according to several factors, including frequency of use, THC exposure, age of first use, and genetic or other vulnerability.
Schizophrenia is a serious psychiatric disorder that can involve hallucinations, delusions, disorganized thinking, and changes in functioning.
Researchers have consistently found an association between cannabis use and schizophrenia-spectrum disorders. The association is particularly strong among people who use cannabis frequently and among those who begin using at a younger age.
Health Canada’s review of the evidence reports that the risk of psychosis or schizophrenia may increase with more frequent cannabis use and that high-potency cannabis has been associated with increased psychosis risk.
Cannabis can also complicate treatment for people who already have psychotic disorders. Continued use may be associated with poorer clinical outcomes for some individuals.
Importantly, schizophrenia has many causes and risk factors. Cannabis is not the sole explanation for why someone develops the disorder. Genetics, brain development, environment, trauma, and other factors can contribute. Where do i buy recreational marijuana Online Melbourne?
The relationship between marijuana and depression is more complicated than the relationship with psychosis.
Studies have frequently found that people who use cannabis, particularly regularly, have higher rates of depressive symptoms or depressive disorders. However, association does not automatically prove that cannabis caused depression.
For example, someone experiencing depression might begin using cannabis in an attempt to relax, escape negative emotions, sleep, or cope with distress. In that situation, depression may partly contribute to cannabis use rather than cannabis being the original cause of depression.
The National Academies found moderate evidence of a small increased risk for developing depressive disorders among cannabis users, but its conclusions also emphasize limitations in the available evidence.
The 2026 Lancet Psychiatry review similarly found that evidence connecting cannabis with depression is less certain than evidence concerning psychosis. Researchers identified possibilities including self-medication, shared risk factors, and bidirectional relationships.
Therefore, it is more accurate to say that frequent cannabis use and depression are associated, while the precise causal relationship varies and remains an active area of research.
Anxiety is another area where people’s experiences with cannabis can differ substantially.
Some users report that marijuana makes them feel calmer. Others experience increased nervousness, racing thoughts, panic, or paranoia.
THC can produce anxiety-like effects, particularly at higher doses. This means a person may experience temporary relaxation at one dose but anxiety or panic at another.
Research on cannabis and anxiety disorders is less conclusive than research on psychosis. The National Academies found limited evidence concerning the development of anxiety disorders overall, but moderate evidence concerning an association between regular cannabis use and social anxiety disorder.
Health Canada’s current public-health guidance also notes that frequent cannabis use can contribute to anxiety and depression and that reducing or stopping frequent use may improve mental health for some people.
People with bipolar disorder may also need to consider cannabis use carefully.
Bipolar disorder involves episodes of depression and episodes of mania or hypomania. Mania can involve unusually elevated or irritable mood, increased energy, reduced need for sleep, impulsivity, and other significant behavioral changes.
The National Academies reported moderate evidence linking regular cannabis use among people with bipolar disorder to increased symptoms of mania and hypomania.
This does not mean cannabis causes bipolar disorder in every person. Rather, cannabis use may interact with an existing vulnerability or disorder and may complicate symptom management.
People receiving treatment for bipolar disorder should therefore discuss cannabis use openly with a qualified healthcare professional rather than assuming that marijuana is harmless because it is perceived as natural.
Researchers have also examined relationships between cannabis use and suicidal ideation and suicide attempts.
The National Academies found moderate evidence of an association between cannabis use and increased incidence of suicidal ideation and suicide attempts, particularly among heavier users.
However, interpreting this evidence requires caution.
Depression, trauma, other substance use, socioeconomic conditions, psychiatric illness, and other factors can affect both cannabis use and suicide risk. Consequently, researchers continue to study whether cannabis itself contributes directly to suicidal behavior or whether much of the observed relationship results from overlapping risk factors.
Regardless of the exact causal pathway, someone experiencing suicidal thoughts should receive professional support rather than attempting to manage the situation with cannabis.
One of the most important factors in cannabis research is age at first use.
The brain continues developing throughout adolescence and into young adulthood. Cannabis exposure during this period may have different implications from use that begins later.
NIDA reports that frequent or heavy cannabis use has been associated with cognitive problems and that cannabis use may be particularly concerning for young people who have genetic vulnerabilities to psychotic disorders.
Research has also identified stronger relationships between cannabis and psychosis when use begins at younger ages.
This does not mean that every teenager who uses cannabis will develop a mental illness. Instead, early and frequent use represents one of several factors that may increase risk.
Yes, evidence suggests that potency matters.
THC is the primary intoxicating cannabinoid in cannabis. Products containing high concentrations of THC can deliver substantially larger amounts of the psychoactive compound than lower-potency products.
Health Canada reports an association between high-potency cannabis and increased risk of psychosis.
High-potency products can also make it easier for users to consume larger amounts of THC than intended. Concentrates, extracts, and some modern cannabis products may contain particularly high THC concentrations.
Consequently, research increasingly considers not only whether someone uses cannabis but also how much THC they are exposed to and how frequently they use it.
Another important issue is cannabis use disorder, sometimes described as problematic cannabis use or cannabis dependence.
Cannabis use disorder can involve:
Strong cravings
Difficulty reducing or stopping use
Spending considerable time obtaining or using cannabis
Continuing to use despite problems
Developing tolerance
Experiencing withdrawal symptoms
Prioritizing cannabis over responsibilities or activities
Mental health difficulties and cannabis use disorder can reinforce one another.
Someone may use cannabis to cope with anxiety or depression. Temporary relief may encourage continued use, while frequent use may contribute to worsening symptoms or dependence. Attempts to stop can then produce irritability, sleep problems, anxiety, or cravings, making the cycle difficult to break.
The WHO recommends screening and brief interventions for adults using cannabis, while people who do not respond to brief interventions may need specialist support.
This is an area where claims often move faster than the evidence.
Cannabis contains numerous cannabinoids, and researchers are studying individual cannabinoids and cannabinoid-based medicines for different medical conditions. However, this does not mean that recreational marijuana is an established treatment for depression, anxiety, schizophrenia, PTSD, or other psychiatric disorders.
The National Academies’ review evaluated cannabis and cannabinoids across several conditions, including anxiety, depression, PTSD, and schizophrenia, but the evidence varies substantially by condition and intervention.
It is therefore important to distinguish between:
Cannabis as a recreational product:
Contains varying amounts of THC and other cannabinoids and may produce intoxication and mental-health effects.
Specific cannabinoid-based medicines:
May contain standardized ingredients and be evaluated for particular medical purposes.
These should not automatically be treated as equivalent.
CBD is different from THC because it does not produce the same intoxicating high.
Researchers are investigating CBD for several potential therapeutic applications. However, evidence for CBD should not automatically be generalized to marijuana as a whole.
A product labeled “CBD” can also vary in concentration, purity, and other ingredients depending on its source and regulatory environment.
More clinical research is needed to establish which CBD preparations, doses, and conditions may have meaningful therapeutic benefits.
Cannabis and mental health research has several important challenges.
First, many studies are observational. Researchers may identify that cannabis users have higher rates of a particular disorder, but observational research cannot always establish exactly why the association exists.
Second, cannabis users may differ from non-users in many other ways. Factors such as alcohol consumption, tobacco use, other drugs, socioeconomic conditions, trauma, family history, genetics, and pre-existing mental health symptoms can influence outcomes.
Third, cannabis itself is not one uniform exposure. Products differ in THC concentration, CBD content, dose, route of administration, and frequency of use.
Fourth, people may change their cannabis use over time.
These limitations are why researchers increasingly use longitudinal studies, genetic approaches, experimental research, and systematic reviews to understand causality.
The overall research picture is becoming clearer in some areas while remaining uncertain in others.
The strongest evidence concerns psychosis. Multiple research approaches indicate that frequent cannabis use, particularly daily use, is associated with increased psychosis risk, and the latest 2026 review found credible evidence for a contributory causal relationship.
For depression, anxiety, bipolar disorder, and suicidal behavior, associations exist but are more difficult to interpret because multiple factors may contribute.
The WHO’s 2026 evidence update emphasizes that cannabis use and cannabis use disorder remain important public-health issues and provides an updated assessment of the health and social consequences of nonmedical cannabis use.
Research suggests particular caution is warranted for people who:
Begin using cannabis during adolescence
Use cannabis daily or almost daily
Use high-THC products
Have a personal history of psychosis
Have a family history of schizophrenia or psychotic disorders
Already have bipolar disorder or another serious mental health condition
Experience anxiety or paranoia after cannabis use
Have difficulty controlling their cannabis consumption
Combine cannabis with other psychoactive substances
A person’s individual risk cannot be determined from cannabis use alone. Personal history, genetics, mental health, age, product characteristics, and frequency of use all matter.
Reducing or stopping frequent cannabis use may improve mental health for some people, although the experience varies.
People who use cannabis frequently can experience withdrawal symptoms after reducing or stopping, including irritability, sleep disturbance, anxiety, reduced appetite, restlessness, and cravings.
For someone who has developed cannabis use disorder, professional assistance can make the process easier.
Health Canada notes that reducing or stopping cannabis use can help improve mental health and brain-function-related problems associated with frequent use.
Anyone experiencing severe anxiety, hallucinations, paranoia, suicidal thoughts, or other serious psychiatric symptoms should seek prompt professional medical assistance.
Research indicates that cannabis use is associated with several mental health conditions, and evidence is strongest for a causal contribution to psychosis. However, mental illness usually has multiple contributing factors, so cannabis should not be considered the sole cause of every psychiatric disorder.
Cannabis use is associated with an increased risk of schizophrenia and other psychotic disorders, particularly with frequent use, early initiation, and high-THC exposure. Not everyone who uses cannabis develops schizophrenia.
Yes. Although some people report temporary relaxation, THC can cause or worsen anxiety, panic, and paranoia, particularly at higher doses.
Current evidence does not establish recreational cannabis as a reliable treatment for depression. The relationship between cannabis and depression is complicated, and some people may use cannabis in response to existing depressive symptoms.
Adolescence is an important period of brain development, and early cannabis use has been associated with increased risks of cognitive and mental-health problems. Frequent use and high-THC exposure are particular concerns.
Evidence suggests that higher-potency cannabis is associated with greater psychosis risk. Higher THC exposure can also produce stronger intoxication and unpleasant psychological effects.
Research on marijuana and mental health has developed considerably over the past several decades. The evidence does not support treating cannabis as universally harmful or universally therapeutic. Its effects depend on factors such as THC potency, frequency of use, age at first use, individual vulnerability, existing mental health conditions, and patterns of consumption.
The clearest finding is the relationship between frequent cannabis use and psychosis. Research indicates that daily or near-daily use, particularly involving high-THC products and early initiation, is associated with greater psychosis risk. Recent evidence has strengthened the conclusion that daily cannabis use can contribute causally to psychosis.
The relationships with depression, anxiety, bipolar disorder, and suicidal behavior are more complex. Associations have been documented, but researchers continue to investigate the extent to which cannabis causes these outcomes, contributes to them, or is used by people who already have underlying mental-health difficulties.
For anyone considering cannabis use, the evidence suggests that frequency, potency, age, and personal or family psychiatric history are important factors to understand. For people already experiencing mental-health symptoms or difficulty controlling cannabis use, speaking with a qualified healthcare professional can provide individualized guidance.
National Institute on Drug Abuse — Cannabis/Marijuana Research
National Academies — Cannabis and Cannabinoids: Mental Health Evidence
Canadian Centre on Substance Use and Addiction — Cannabis and Mental Health
PubMed — Systematic Review of Cannabis and Psychotic/Affective Outcomes
The Lancet Psychiatry — Cannabis Use and Mental Disorders Review, 2026
World Health Organization — Mental Health and Substance-Use Interventions